Home
Conditions
Schizophrenia Spectrum and Other Psychotic Disorders

Clinical trial condition

Schizophrenia Spectrum and Other Psychotic Disorders

Explore clinical trials studying Schizophrenia Spectrum and Other Psychotic Disorders. Study availability and eligibility vary by location and protocol.

3,091 public trials 348 recruiting studies

Refine in advanced search Browse all conditions

Schizophrenia Spectrum and Other Psychotic Disorders trial results

Completed

A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)

NCT02694328

Conditions: Body Weight, Mental Disorders, Pathological Conditions, Signs and Symptoms, +3 more
Locations: Alkermes Investigational Site Little Rock, Arkansas, United States

Alkermes Investigational Site Springdale, Arkansas, United States

Alkermes Investigational Site Anaheim, California, United States

Alkermes Investigational Site Cerritos, California, United States

View all 54 locations

View Trial Details

Completed

Evaluating a Novel Mobile App for Social Cognition in Psychosis

NCT04260763

Conditions: Mental Disorders, Psychotic Disorders, Schizophrenia, +2 more
Locations: King's College London London, United Kingdom

View Trial Details

Completed

Prospective Studies of the Pathogenesis of Schizophrenia

NCT00877552

Conditions: Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
Locations: UNC Department of Psychiatry Chapel Hill, North Carolina, United States

View Trial Details

Completed

Therapeutic Effect of Cassia Seed in Obesity of Patients With Schizophrenia

NCT04252131

Conditions: Body Weight, Mental Disorders, Nutrition Disorders, +8 more
Locations: Calo Psychiatric Center Pingtung City, Others, Taiwan

View Trial Details

Completed

A Study of Lurasidone HCl in Subjects With Schizophrenia

NCT03393026

Conditions: Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
Locations: Taipei City Hospital, Songde Branch Taipei, Taiwan

Tri-Service General Hospital Taipei, Taiwan

View Trial Details

Completed

Phase 2 Trial of a Nicotinic Agonist in Schizophrenia

NCT00100165

Conditions: Mental Disorders, Schizophrenia, Schizophrenia Spectrum and Other Psychotic Disorders
Locations: VA Eastern Colorado Health Care System, Denver, CO Denver, Colorado, United States

View Trial Details

Completed

Action-based Cognitive Remediation for First Episode Psychosis

NCT03814122

Conditions: Cognition Disorders, Cognitive Dysfunction, Cognitive Impairment, +5 more
Locations: Crisis Response Centre Winnipeg, Manitoba, Canada

View Trial Details

Completed

Clinical and Genetic Influencing Factors on Clozapine Pharmacokinetics

NCT04240496

Conditions: CYP1A2 Polymorphism, CYP2C19 Polymorphism, Clozapine, +3 more
Locations: Faculty of Medecine of Monastir Monastir, Tunisia

View Trial Details

Completed

Effect of 4-session Metacognitive Training in Chinese Adult Outpatients With Schizophrenia Spectrum Disorders and Major Depressive Disorder

NCT03449394

Conditions: Behavior, Behavioral Symptoms, Delusions, +4 more
Locations: Chinese University of Hong Kong Hong Kong

View Trial Details

Completed

Symptom Based Treatment Affects Brain Plasticity - the Role of Verbal Auditory Hallucinations

NCT02722915

Conditions: Hallucinations, Hallucinations, Verbal Auditory, Mental Disorders, +8 more
Locations: University Hospital RWTH Aachen, Department of Psychiatry, Psychotherapy and Psychosomatics Aachen, Germany

View Trial Details

Schizophrenia Spectrum and Other Psychotic Disorders

Schizophrenia Spectrum and Other Psychotic Disorders trial results

Related conditions